secwatch / observer
8-K filed September 28, 2023, 7:59 PM ET ticker KPRX CIK 0001372514
other material confidence high sentiment neutral materiality 0.15

Kiora shareholders approve 1M-share equity plan increase and >20% issuance to Lincoln Park Capital

KIORA PHARMACEUTICALS INC

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

KIORA PHARMACEUTICALS INC shareholders approved Approval of an amendment to the 2014 Equity Incentive Plan to increase the maximum number of shares authorized for issuance by 1,000,000 shares and to revise the evergreen provision at the 2023-09-27 meeting.

Proposal
equity plan
Outcome
passed
Meeting
2023-09-27
Exact text from the filing
Proposal 1 – Approval of Equity Incentive Plan Amendment The amendment to the Company’s 2014 Equity Incentive Plan to increase the maximum number of shares authorized for issuance thereunder by 1,000,000 shares and to revise the provision governing the maximum shares issuable under the evergreen provision was approved. The results of the election were as follows: Voted For Votes Against Votes Abstained 1,872,064 612,104 264,210
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

KIORA PHARMACEUTICALS INC shareholders approved Approval of the issuance of more than 20% of the Company’s issued and outstanding common stock pursuant to the purchase agreement with Lincoln Park Capital Fund, LLC at the 2023-09-27 meeting.

Outcome
passed
Meeting
2023-09-27
Exact text from the filing
Proposal 2 - Approval of the Issuance of More Than 20% of the Company’s Issued and Outstanding Common Stock Pursuant to the Company’s Purchase Agreement with Lincoln Park The approval, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of more than 20% of the Company’s issued and outstanding common stock pursuant to the Company’s purchase agreement with Lincoln Park Capital Fund, LLC, was approved. The results of the vote were as follows: Votes For Votes Against Votes Abstained 2,051,285 432,684 264,409
View on SEC.gov

Browse all shareholder votes →

KIORA PHARMACEUTICALS INC filing history →

Source: SEC EDGAR
accession 0001372514-23-000132
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.